>_ QFI Terminal
Terminal › Stocks › SHC

Sotera Health Company (SHC) Stock

Healthcare · Medical - Diagnostics & Research · US
$16.44 +1.04%
Last updated Nov 12, 2026 09:20 UTC

SHC Key Statistics

Market Cap$4.69B
P/E (TTM)27.39
P/S (TTM)3.81
P/B (TTM)6.41
Revenue (TTM)$1.23B
EPS (TTM)$0.60
Dividend Yield—
ROE (TTM)26.41%
Net Margin14.11%
Gross Margin54.62%
52W High$19.85
52W Low$13.09
Analyst ViewBuy
Price Target$21.33
Employees3,000
Volume2,894,675

About Sotera Health Company

Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.

CEO: Alton E. Shader. Company website

SHC — Frequently Asked Questions

What is the SHC stock price today?

Sotera Health Company (SHC) trades at $16.44, up 1.04% on the day, as of Nov 12, 2026 09:20 UTC.

What is Sotera Health Company's market cap?

Sotera Health Company has a market capitalisation of $4.69B, calculated from the live SHC share price and shares outstanding.

What is the P/E ratio of SHC?

SHC trades at a trailing P/E of 27.39, from earnings per share of $0.60 over the last twelve months.

How much revenue does Sotera Health Company make?

Sotera Health Company generated revenue of $1.23B over the trailing twelve months, which puts the stock at 3.81 times sales.

What is the 52-week range for SHC?

SHC has traded between $13.09 and $19.85 over the past 52 weeks, and the last price is 17.2% below that high.

Is Sotera Health Company profitable?

Yes. Sotera Health Company keeps 14.11% of revenue as net income over the trailing twelve months.

What is the analyst price target for SHC?

Wall Street analysts rate SHC Buy, with an average price target of $21.33, 29.7% above the current price.

What sector is Sotera Health Company in?

Sotera Health Company is classified under the Healthcare sector and the Medical - Diagnostics & Research industry, and is domiciled in US.

Who is the CEO of Sotera Health Company?

Alton E. Shader is the chief executive of Sotera Health Company, which employs 3,000 people.

Where can I track SHC in real time?

QFI Terminal shows SHC with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See SHC live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open SHC in Terminal See plans

Medical - Diagnostics & Research stocks

TMO Thermo Fisher Scientific Inc. DHR Danaher Corporation IQV IQVIA Holdings Inc. LH Labcorp Holdings Inc. DGX Quest Diagnostics Incorporated ICLR ICON Public Limited Company A Agilent Technologies, Inc. WAT Waters Corporation IDXX IDEXX Laboratories, Inc. ILMN Illumina, Inc. MTD Mettler-Toledo International Inc. CRL Charles River Laboratories International, Inc. EXAS Exact Sciences Corporation RVTY Revvity, Inc. NTRA Natera, Inc. MEDP Medpace Holdings, Inc. QGEN Qiagen N.V. GH Guardant Health, Inc. MYGN Myriad Genetics, Inc. NEO NeoGenomics, Inc. NOTV Inotiv, Inc. OPK OPKO Health, Inc. ATLN Atlantic International Corp. CDNA CareDx, Inc

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. CNC Centene Corp. ELV Elevance Health Inc. HUM Humana Inc. JNJ Johnson & Johnson LLY Eli Lilly and Company HCA HCA Healthcare, Inc. MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc.

ETFs holding SHC

SCHA Schwab U.S. Small-Cap ETF 0.11% IWD iShares Russell 1000 Value ETF 0.01% VTI Vanguard Morningstar Total Stock Market ETF 0.01% IWB iShares Russell 1000 ETF 0.01% SCHB Schwab U.S. Broad Market ETF 0.01% VT Vanguard Total World Stock ETF 0.00%

Largest institutional holders of SHC

Sessa Capital IM, L.P. 27,050,000 shares
Darsana Capital Partners LP 27,000,000 shares
BlackRock, Inc. BLK 24,148,424 shares
Sculptor Capital LP 24,000,000 shares
Sachem Head Capital Management LP 15,560,000 shares
VANGUARD CAPITAL MANAGEMENT LLC 12,170,699 shares
VANGUARD PORTFOLIO MANAGEMENT LLC 11,946,341 shares
AQR CAPITAL MANAGEMENT LLC 10,734,313 shares
T. Rowe Price Investment Management, Inc. 10,518,373 shares
Jupiter Topco LLC 8,402,106 shares

SHC insiders on other boards

YUMC Yum China Holdings, Inc. Dimitrief Alexander SON Sonoco Products Company Kyle Richard G TKR The Timken Company Kyle Richard G HAE Haemonetics Corporation Simon, Christopher WAB Westinghouse Air Brake Technologies Corporation Klee Ann R. ROL Rollins, Inc. Krause Kenneth D. AIT Applied Industrial Technologies, Inc. Petrella Vincent K WEX WEX Inc. Neary James